Fuse Science, Inc. (OTCMKTS:DROP) Manages to Close The Week Decently
Fuse Science, Inc. (OTCMKTS:DROP) saw some intense trading last week, with the price swaying in both directions and massive amounts of traded stock. The main reason for the heated week was the investment announcement from November 8, which we covered in our previous article and led to some dissapointing results in the first sessions.
DROP recorded the biggest percentile loss in a while last Wednesday, but somehow managed to regain some of its value in the following sessions and ended the week well, without the aid of optimistic press releases or promotions.
Indeed we saw some PR in Friday, but it was posted well after market open and didn’t cause much movement. The press release was announcing that Macular Health, LLC, a partner of DROP will be showcasing their MacuDropTM AREDS II Formula at the American Academy of Ophtalmology.
In the end DROP finished Friday’s session with a 18% gain on a smaller volume than the previous session’s that was still way above the stock’s average. The total amount of shares that switched hands came at 13 million and generated $644 thousand in dollar volume.
In the end, over the course of Thursday’s and Friday’s sessions DROP managed to regain the huge 29% drop from Wednesday and closed the week priced at $0.032 per share.
Penny Stock Prophecy moved in on Saturday in an effort to make a good image for themselves, but we don’t think that this will affect the movement in any way. And we sure hope it doesn’t, because we have just seen how bad it can get after some promoter tries to advertise itself with climbing stocks.
InVivo Therapeutics Holdings Corp. (OTCMKTS:NVIV) also closed the week good, with a whopping 55% gain on high volumes that generated $3.5 million in trade value. This was the biggest percentile movement we see from NVIV in a while. Nano Labs Corp. (OTCBB:CTLE) were not so fortinate and the ended the week in the red after 4 sessions of climbing the charts.
